-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $7

Benzinga·03/26/2026 12:47:23
Listen to the news
Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target from $8.5 to $7.